Multiple cancers. Tumor burden permits the outgrowth of other cancers

doi:10.1084/jem.162.5.1665

This Article

	Full Text (PDF, 1089K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Mullen, C. A.
	Articles by Schreiber, H.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Mullen, C. A.
	Articles by Schreiber, H.


Social Bookmarking

	What's this?

ARTICLES

Multiple cancers. Tumor burden permits the outgrowth of other cancers

CA Mullen, JL Urban, C Van Waes, DA Rowley and H Schreiber

We demonstrate that tumor-bearing hosts permit the outgrowth of "potentially malignant" cells that are located at a different site. These second cancers continued to grow and kill their hosts even though they retain the "premalignant" phenotype, even after removal of the original malignancy. The potentially malignant cells used in these experiments were ultraviolet light- or methylcholanthrene-induced regressor tumor cells that are rejected regularly by normal mice at any testable dose, and only form progressive tumors in immunosuppressed individuals. The immunological rejection of these highly immunogenic, potentially malignant cells was suppressed by Thy-1+, Ly-2-, nonadherent, radio-sensitive suppressor cells in the tumor-bearing mice. These suppressor cells were absent in nude tumor-bearing mice. Unlike helper and cytolytic T cell-mediated responses, which are exquisitely tumor specific, the suppression caused by a progressively growing tumor was crossreactive among many syngeneic, independently derived tumors induced by different carcinogens. However, T cell- mediated immune responses to alloantigens, allogeneic tumors, certain syngeneic tumors, and humoral responses to xenogeneic red blood cells were normal in these mice. The immune suppression in the tumor-bearing animals closely simulated that induced by ultraviolet light irradiation, and both types of suppression might therefore share common mechanisms. Our findings may contribute to understanding the growth, development, and possible control of multicentric malignancies and add a precaution to the potential use of strongly immunogenic tumor variants for active immunotherapy in hosts bearing less immunogenic tumors.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Willimsky, G., Czeh, M., Loddenkemper, C., Gellermann, J., Schmidt, K., Wust, P., Stein, H., Blankenstein, T. (2008). Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness. JEM 205: 1687-1700 [Abstract] [Full Text]
Spiotto, M. T., Reth, M. A., Schreiber, H. (2003). Genetic changes occurring in established tumors rapidly stimulate new antibody responses. Proc. Natl. Acad. Sci. USA 100: 5425-5430 [Abstract] [Full Text]
Bai, X.-F., Bender, J., Liu, J., Zhang, H., Wang, Y., Li, O., Du, P., Zheng, P., Liu, Y. (2001). Local Costimulation Reinvigorates Tumor-Specific Cytolytic T Lymphocytes for Experimental Therapy in Mice with Large Tumor Burdens. J. Immunol. 167: 3936-3943 [Abstract] [Full Text]
Anderson, L. D. Jr., Mori, S., Mann, S., Savary, C. A., Mullen, C. A. (2000). Pretransplant Tumor Antigen-specific Immunization of Allogeneic Bone Marrow Transplant Donors Enhances Graft-versus-Tumor Activity without Exacerbation of Graft-versus-Host Disease. Cancer Res. 60: 5797-5802 [Abstract] [Full Text]
Radoja, S., Rao, T. D., Hillman, D., Frey, A. B. (2000). Mice Bearing Late-Stage Tumors Have Normal Functional Systemic T Cell Responses In Vitro and In Vivo. J. Immunol. 164: 2619-2628 [Abstract] [Full Text]
Matsuo, M., Wada, H., Honda, S., Tawara, I., Uenaka, A., Kanematsu, T., Nakayama, E. (1999). Expression of Multiple Unique Rejection Antigens on Murine Leukemia BALB/c RL[IMAGE]1 and the Role of Dominant Akt Antigen for Tumor Escape. J. Immunol. 162: 6420-6425 [Abstract] [Full Text]
Anderson, L. D. Jr., Petropoulos, D., Everse, L. A., Mullen, C. A. (1999). Enhancement of Graft-Versus-Tumor Activity and Graft-Versus-Host Disease by Pretransplant Immunization of Allogeneic Bone Marrow Donors with a Recipient-derived Tumor Cell Vaccine. Cancer Res. 59: 1525-1530 [Abstract] [Full Text]
Dubey, P., Hendrickson, R. C., Meredith, S. C., Siegel, C. T., Shabanowitz, J., Skipper, J. C.A., Engelhard, V. H., Hunt, D. F., Schreiber, H. (1997). The Immunodominant Antigen of an Ultraviolet-induced Regressor Tumor Is Generated by a Somatic Point Mutation in the DEAD Box Helicase p68. JEM 185: 695-706 [Abstract] [Full Text]